The legal battle between Epic Systems and Particle Health has captured the attention of the healthcare industry. Particle Health has filed an antitrust lawsuit against Epic Systems, accusing the electronic health record (EHR) giant of engaging in monopolistic and anticompetitive practices. This
As 2024 recedes into the annals of history, the spotlight on artificial intelligence (AI) in the medtech industry has only grown brighter. Major players like GE Healthcare, Medtronic, and Dexcom have introduced new AI features, while companies such as Stryker and Quest Diagnostics have expanded
On January 7, Cayuga Health and Arnot Health announced their intention to merge and form a new healthcare system named Centralus Health. This merger, which has been in the works since April 2023, is still awaiting regulatory approval from the New York State Department of Health (DOH). Despite the
In a groundbreaking development in medical imaging, Bayer has introduced a new gadolinium-based contrast agent (GBCA) known as gadoquatrane, which has demonstrated the capability to use 60% less gadolinium compared to traditional agents while maintaining high imaging quality. This innovation is
The Drug Enforcement Administration (DEA) has unveiled a series of proposed updates aimed at reshaping the landscape of controlled substance prescriptions via telemedicine. Issued as a notice of proposed rulemaking (NPRM) on January 15, 2025, these regulations seek to introduce a more stringent
The European Union has introduced the Cyber Resilience Act (CRA), a comprehensive regulation that mandates the cybersecurity responsibilities of manufacturers, distributors, and retailers of smart connected devices. As the world becomes increasingly dependent on connected technology, it is crucial
The U.S. Drug Enforcement Agency (DEA) has recently unveiled a regulatory framework aimed at governing the telehealth prescribing of controlled substances. This initiative seeks to maintain the accessibility of telehealth services that became prevalent during the COVID-19 pandemic while ensuring
Noom, a prominent name in digital health known for its focus on chronic disease prevention, has recently announced the inclusion of oral medications within its Noom Med program. Noom Med was launched to expand the company's efforts in building healthier habits through psychological tools, food
CW1 Group has launched a groundbreaking Artificial Intelligence (AI) platform aimed at revolutionizing hospital operations and healthcare delivery globally. As a major player in the healthcare and research industry, CW1's initiative marks a significant departure from traditional consulting
The Food and Drug Administration (FDA) has recently released new guidelines aimed at addressing racial bias in pulse oximeters. These devices, which measure oxygen levels in the blood, have shown discrepancies in accuracy, particularly for people with darker skin tones. This issue has led to
